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Endocrine disrupting chemicals are adversely affecting the reproductive health and meta-
bolic status of aquatic vertebrates. Estrone is often the dominant natural estrogen in urban
sewage, yet little is known about its environmental fate and biological effects. Increased
use of UV-B radiation for efﬂuent treatments, and exposure of efﬂuents to sunlight in
holding ponds led us to examine the effects of environmentally relevant levels of UV-B
radiation on the photodegradation potential of estrone. Surprisingly, UV-B-mediated degra-
dation leads to the photoproduction of lumiestrone, a little known 13α-epimer form of
estrone. We show for the ﬁrst time that lumiestrone possesses novel biological activity.
In vivo treatment with estrone stimulated estrogen receptor (ER) α mRNA production in
the male goldﬁsh liver, whereas lumiestrone was without effect, suggesting a total loss
of estrogenicity. In contrast, results from in vitro ER-dependent reporter gene assays indi-
cate that lumiestrone showed relatively higher estrogenic potency with the zebraﬁsh ERβ2
than zfERα, suggesting that it may act through an ERβ-selectivity. Lumiestrone also acti-
vated human ERs. Microarray analysis of male goldﬁsh liver following in vivo treatments
showed that lumiestrone respectively up- and down-regulated 20 and 69 mRNAs, which
was indicative of metabolic upsets and endocrine activities. As a photodegradation product
from a common estrogen of both human and farm animal origin, lumiestrone is present in
sewage efﬂuent, is produced from estrone upon exposure to natural sunlight and should
be considered as a new environmental contaminant.
Keywords: environmental estrogens, estrone, lumiestrone, fish, endocrine disruption, liver, sewage effluents,
photochemistry
INTRODUCTION
There is strong evidence linking exposure to estrogenic endocrine
disrupting chemicals (EDCs) with the feminization of male
wildlife, the decline of some species, and potential effects on
human development and fertility (Guillette et al., 2007; Kidd et al.,
2007; Hotckiss et al., 2008; Ottinger et al., 2008; Desforges et al.,
2010; Mouritsen et al., 2010; Harris et al., 2011). Estrogenic chem-
icals also have effects in mollusks (Hotckiss et al., 2008) and even
plants (Fox et al., 2004). Some EDCs have been linked to metabolic
upsets and obesity (Decherf and Demeneix, 2011). Nevertheless,
great debate continues on whether environmental levels of these
and other EDCs are sufﬁciently biologically active to be of con-
cern. However, the key examples of feminization of alligators and
ﬁsh, and the decline and elimination of some species following
contamination of lakes clearly indicates that environmental estro-
gens are affecting wildlife on a large scale (Guillette et al., 2007;
Kidd et al., 2007; Hotckiss et al., 2008; Desforges et al., 2010). Per-
haps most convincing is the ecosystems level study by Kidd et al.
(2007). They reported on experimental contamination of a large
(34 ha) freshwater lake in the Experimental Lakes Area of Canada
with the contraceptive ethinyl-estradiol (EE2). This direct addi-
tion of EE2 led to the feminization of male fathead minnows as
indicated by the production of the egg yolk protein vitellogenin,
intratesticular ovarian tissues, and near extinction of the species
from the lake (Kidd et al., 2007). In wild roach in UK rivers, femi-
nization resulting from pollution is a major problem that is linked
to reduced fertility (Harris et al., 2011). Most studies on estro-
genic EDCs in human wastewater efﬂuents focus either on EE2 or
the natural steroid estradiol 17-β (E2). This is surprising given that
estrone (E1) is often the most abundant estrogen in the wastewater
of some sewage treatment facilities (Williams et al., 2003; Johnson
et al., 2005; Servos et al., 2005; Kumar et al., 2011), is found in farm
sewage (Hutchins et al., 2005), soil (Ying and Kookana, 2005), and
ocean sediments (Braga et al., 2004). Moreover, surprisingly little
is known about the biological activity of E1 in aquatic vertebrates.
The investigation of steroidal estrogen behavior under ultra-
violet (UV) radiation is important because when estrogens are
released to the environment, they are exposed to solar radiation
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(UVA; λ= 320–400 nm, and UV-B; λ= 280–320 nm). Estrone,
17β-estradiol (E2), and 17α-ethinyl-estradiol (EE2) are candi-
dates for UV photodegradation because they show maximum
absorbance peaks in the UV spectrum (Coleman et al., 2004).
Not reaching the earth’s surface is the highly destructive UVC
band (λ= 240–280 nm) that is ﬁltered by the ozone layer. How-
ever, UVC lamps are used widely in STP treatment as an effective
disinfection tool (Das, 2001). Combinations of UV and other
remediation methods for the removal and degradation of E1 and
other estrogens have also been reported (Coleman et al., 2004; Lin
and Reinhard, 2005). Yet, the environmental fate of E1 and many
other EDCs is still controversial. We (Atkinson et al., 2011) and
others (Coleman et al., 2004; Liu and Liu, 2004) have reported on
UV-mediated degradation of E1, and in some cases there appears
to be some reduction in estrogenicity. On the other hand, some
studies report no effect of UV on estrogen degradation (Cicek
et al., 2007). In the course of our previous investigations (Atkinson
et al., 2011) we found that UV-mediated degradation of E1 led to
the formation of an unknown product that we identify and char-
acterize here. We found that E1 can be rapidly photochemically
converted to lumiestrone, a little known steroid that we also deter-
mined to be biologically active, rapidly produced upon natural
sunlight exposure and present in urban sewage efﬂuent.
MATERIALS AND METHODS
DETECTION OF ESTROGENS
One liter water grab samples of sewage efﬂuents were collected in
amber, air-tight bottles thatwere pre-rinsedwith dichloromethane
(ACS grade, Fisher Scientiﬁc) and baked overnight at 200˚C.Water
samples were stored in the dark at 4˚C for up to 48 h. Imme-
diately after sampling an isotope dilution was done by adding a
C-13 labeled internal standards (Cambridge Isotope Laboratories,
Andover, MA, USA) of E1, E2, and EE2 in acetonitrile. Extraction
and analysis for steroidal estrogens followed previous strategies
(Lee and Peart, 1998; Kuch and Ballschmiter, 2001) as validated in
our laboratory (Atkinson et al., 2011).The sampleswere preﬁltered
through a 1.2-μm glass ﬁber ﬁlter and subsequently loaded onto a
pre-treated 1 g ENVI-18 solid phase extraction (SPE) cartridge at
a ﬂow rate of 10mL/min. The SPE was eluted with 5mL acetone
followed by 5mL methanol. The extract was evaporated to dry-
ness with nitrogen gas, and re-dissolved in 2mL of high-pressure
liquid chromatography (HPLC) water. A 10% pentaﬂuorobenzoyl
chloride derivative in toluene and 2M potassium hydroxide was
added to the sample and vortexed. After phase separation, the
organic phase was extracted twice with 2.5mL hexane and evap-
orated to 0.5mL. The sample was subsequently passed through a
sodium sulfate column, eluted with 7mL of hexane, and evapo-
rated to 200μl for analysis on an Agilent 6890 gas chromatograph
with a 5973 Mass Selective Detector in negative chemical ioniza-
tion mode. One microliter was injected onto a Zebron ZB-5MS
30m, 250μm, 0.25μm column with a ﬂow rate of 1mL/min of
helium gas. The oven ramping commenced with 80˚C held for
1min, increasing at 24˚C/min to 200˚C and held for half a minute,
73˚C/min until 245˚C and held for 5min, and then 1˚C/min to
260˚C. The mass spectrometer used methane as the reaction gas at
a ﬂow rate of 40mL/min with the quad at 100˚C and the source at
200˚C. The 12C ions monitored were E1/lumiestrone 464, E2 466,
and EE2 490 and the 13C ions were 466, 468, and 492, respectively.
Both E1 and lumiestrone produced identical ion fragmentation
patterns, and were quantiﬁed using identical protocols. Chro-
matographic data were collected and analyzed using Agilent MSD
Chemstation Data Analysis Software.
The method detection limits (MDLs) were calculated using the
protocol of the United States Environmental Protection Agency
(1993). The MDLs were obtained by injection of seven extracts
from seven water samples (prepared from E1 and EE2 standards of
5 and 1 ng L−1, respectively, in 1 L double distilled water), where
the SD for the mean concentration was multiplied by the one-
tailed t statistic at a 95% conﬁdence level. In addition, the linear
responses of steroidal estrogens were determined from sample
extracts of 0, 12.5, 25, 37.5 ng L−1 of E1 standards and from sam-
ple extracts of 0, 1, 2, 3, and 4 ng L−1 of EE2 standards. Blank
samples of double distilled water and blank samples of hydroma-
trix were spiked with the 13C standards and taken through the
extraction process. The MDL for E1 and EE2 in water were 1.8
and 0.3 ng L−1 respectively. No commercial standards are avail-
able for lumiestrone, but its ion fragmentation pattern and MDL
are identical to E1.
PURIFICATION AND CHARACTERIZATION OF LUMIESTRONE
Mid-day UV-B intensity along the Ottawa River (Ontario), typical
of a partly cloudy day in summer was measured to be ∼110–
140mWcm−2 using the GOLDILUX radiometer/photometer
GRP-1 (Model 70237) with anUV-BRprobeGBP-1 (Model 0238).
This measurement was used to design environmentally relevant
UV exposures in controlled laboratory conditions. In another
experiment, a solution of E1 (0.1mM)dissolved in acetonitrilewas
irradiatedwithUVC in a photoreactor (model LZC-4V,Luzchem).
Under various experimental conditions, the disappearance of
E1 and the formation of its main photoproduct (lumiestrone)
were followed by gas chromatography (GC); the solution was
injected directly after irradiation on the column (Agilent HP-5MS,
0.25mm× 30m× 0.25μm) of the GC/MS chromatogram (Agi-
lent Technologies). The injector temperature was set at 250˚C.
The temperature program began at 50˚C (for 10min) and was
increased up to 280˚C (for 10min) at a rate of 10˚C/min. The
temperature of the MS detector (Agilent, model 5973) was set at
150˚C. In these conditions, by using 7 UVC lamps in the photore-
actor, the almost complete conversion of E1 into lumiestrone was
observed after 5min irradiation. Lumiestronewas then puriﬁed by
preparative high performance liquid chromatography. The puriﬁ-
cation was carried out on a preparative system from Shimadzu
(model: LC-8A) equipped with a UV-detector (model: SPD-10A),
the column employed was a preparative reverse-phase C-18 col-
umn (Supelco, discovery HS C-18, 250mm × 21.2mm× 5μm).
Lumiestrone was obtained as a pure product after 17min using
an isocratic elution with 70% acetonitrile and 30% water and a
ﬂowof 10mL/min. Lumiestronewas then characterized by nuclear
magnetic resonance spectroscopy (NMR; Fielding et al., 2001).
NMR spectra were recorded at 400MHz for [1H] and 100MHz
for [13C] on a Bruker Avance 400 spectrometer. The carbon multi-
plicity was assessed by distortionless enhancement by polarization
transfer (DEPT). The proton couplings were evidenced by 1H–1H
COSY experiments. The heteronuclear chemical shift correlations
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were determined by HMQC and HMBC pulse sequences. The
sample was prepared in methyl sulfoxide-d6 (99%) purchased
from Aldrich.
IN VITRO REPORTER GENE ASSAYS
The zebraﬁsh (zf) zfERα, zfERβ1, and zfERβ2 expression vectors,
correspond to Topo-pcDNA3 expression vector (Invitrogen, San
Diego, CA, USA), containing the coding regions of each recep-
tor cDNA, as previously described (Menuet et al., 2002; Métivier
et al., 2002). The cyp19b–Luc reporter gene consists of 500 bp of
the proximal promoter region of zebraﬁsh cyp19b gene, contain-
ing an estrogen response element (ERE), coupled to the ﬁreﬂy
luciferase reporter gene (Le Page et al., 2006, 2008). The ERE-tk-
Luc reporter gene consists of a consensus ERE with a minimal
thymidine kinase promoter driving ﬁreﬂy luciferase activity. The
cytomegalovirus–β-galactosidase (CMV–βgal) was used as control
internal plasmid. These vectorswere describedpreviously (Menuet
et al., 2002; Métivier et al., 2002). The U251-MG (ER-negative
glial cell line) and MCF-7 (ER-positive breast cancer cell line) cells
were maintained at 37˚C under a 5% CO2 atmosphere in Dul-
becco’s modiﬁed Eagle medium (DMEM; Sigma, St. Louis, MO,
USA) supplemented with 10% fetal calf serum (FCS; Life Tech-
nologies, Carlsbad, CA, USA), 100U/mL penicillin, 100mg/mL
streptomycin, and 25mg/mL amphotericin (Sigma–Aldrich, St.
Louis, MO, USA). U251-MG cells were plated in 24-well plates at
a density of 0.2× 105 cells/mL. U251-MG were transfected with
25 ng of zfER expression vector, 150 ng of luciferase reporter con-
struct and 25 ng of CMV–βgal control plasmid.MCF-7were plated
in 24-well plates at a density of 0.5× 105 cells/mL and transfected
with 50 ng of ERE-TK-Luc and 25 ng of CMV–βgal perwell. Trans-
fection assayswere performedwithFuGENE6 transfection reagent
(Roche, Basel, Switzerland). After one night,medium was replaced
with fresh DMEM-F12 containing 2% charcoal/dextran FCS with
estrogenic test chemical or vehicle. The luciferase activities were
assayed 48 h later using the luciferase assay system (Promega,
Madison,WI,USA).We used β-galactosidase activity to normalize
for transfection efﬁciency in all experiments. Each experiment was
performed at least in triplicate.
IN VIVO TREATMENTS AND GENE EXPRESSION ANALYSIS
All in vivo protocols were approved by the University of Ottawa
Animal Care and Veterinary Services and were in accordance
with the Canadian Council on Animal Care. Sexually regressed
male goldﬁsh were injected intraperitoneally with E2 (0.5μg/g),
E1 (0.5μg/g), and lumiestrone (0.5μg/g) or control vehicle (in
charcoal-stripped peanut oil; 5μL/g). Animals were anesthetized
in MS222, and livers were harvested 24 h after injection, frozen on
dry ice, and stored at −80˚C until RNA extraction, cDNA synthe-
sis and real-time multiplex PCR analysis for the three ﬁsh ERs or
vitellogenin-1 by a SYBR-green-based simplex assay as validated in
our laboratory (Marlatt et al., 2008) using the Mx4000® Multiplex
Quantitative PCR System (Stratagene, La Jolla, CA,USA). Analysis
of the ∼10K carp-goldﬁsh microarray data including statisti-
cal analysis followed our established and well-validated strategies
(Gracey et al., 2004; Martyniuk et al., 2006; Williams et al., 2008).
Pooled control liver cDNA was hybridized against four inde-
pendent samples from lumiestrone-treated males. Hybridizations
were performed using the protocol supplied by Genisphere.
Microarrays were scanned at full speed 10 μm resolution using
the ScanArray 5000 XL system (Packard Biosciences/PerkinElmer)
using both red and blue lasers. Images were obtained with Sca-
nArray Express software using automatic calibration sensitivity
varying PMT gain (PMT starting at 65% for Cy5 and 70% for Cy3)
with ﬁxed laser power at 80% and the target intensity set for 90%.
Microarray images were analyzed using QuantArray (Packard
Biosciences/Perkin Elmer) and raw signal intensity values were
obtained for duplicate spots of genes. We used Alien Spot Report
Genes 1–10 (Stratagene, La Jolla, CA, USA) to normalize microar-
ray data and the Signiﬁcance Analysis of Microarray method
(Tusher et al., 2001; SAM) formicroarray analysis. Candidate genes
identiﬁed as being differentially regulated (q-value< 5) were fur-
ther analyzed using the GOSSIP package in Blast2GO (Conesa
et al., 2005) for gene ontology categorizations. Themicroarray data
are accessible via the Gene Ontology Omnibus at NCBI (accession
no. GSE12252).
RESULTS AND DISCUSSION
When E1 was placed in either distilled water or river water
and exposed to an environmentally relevant level of UV-B
(135mWcm−2), a photodegradation product of the same mol-
ecular weight as E1 was obtained. This shows that the process
is direct and not a photosensitized reaction. The appearance of
this unknown photoproduct conﬁrms our previous observations
(Atkinson et al., 2011). This photoproduct was isolated by prepar-
ative HPLC and characterized by NMR as the 13α-epimer form of
E1, lumiestrone [Estra-1,3,5(10)-trien-17-one, 3-hydroxy-, (13α)-
(9CI)]. To determine the process of formation of lumiestrone, a
series of fundamental photochemical experiments were realized
in organic solvent. As observed, brief irradiation of E1 with UV-
B under aerobic conditions in acetonitrile leads to the almost
complete conversion of E1 into lumiestrone (Figure 1). Longer
irradiations induce the complete disappearance of E1, and eventu-
ally lumiestrone, indicating that the photoproduct is more robust
than the parent compound (Figure 1).
Electron paramagnetic resonance spectroscopy using gaseous
nitric oxide (NO•) as the spin trap coupled to irradiation of an E1
solution yields a nitroxide radical signal (aN = 7.3G; Figure A1
in Appendix) very close to the one reported for cyclopen-
tanone (Maruthamuthu and Scaiano, 1978). This proves that
13α-epimerization of E1 is via the Norrish type I photocleavage of
a cyclic ketone as depicted in Figure 2.
Nanosecond laser ﬂashphotolysis experimentswere alsounder-
taken. Lumiestrone was produced and no traces of bi-radical
formation were observed in the nanosecond time scale, indicating
a rapid conversion (<20 ns) of E1 to lumiestrone. UVA was also
used in order to photodamage E1 but no phototransformations
were observed since E1 does not absorb in this region. Signiﬁ-
cantly, UV-B irradiation of E1 in water (with <1% ethanol) also
leads to the formation of a single product, lumiestrone (Figure A2
in Appendix). Untreated sewage water obtained from the Mer-
cato san Severino sewage treatment plant (Salerno, Italy) was
ﬁltered to remove grit. Estrone was dissolved in this sewage water
and irradiated by natural sunlight in July in Napoli, Italy. This
is environmentally relevant because efﬂuents can be exposed to
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FIGURE 1 | Conversion of estrone into lumiestrone in acetonitrile
following exposure to UV-B radiation, followed by gas
chromatography. Irradiation times were (A) 0min, (B) 5min, (C) 15min,
(D) 30min.
FIGURE 2 | Proposed mechanism for the phototransformation of
estrone into lumiestrone.
sunlight in holding ponds or as they are released to the receiv-
ing environment. Degradation is slower than under laboratory
conditions, probably related to reduced penetration of UV-B in
a dark sewage sample relative to clear water, but lumiestrone is
still the only photodegradation product (Figure A3 in Appendix).
Lumiestrone could be detected by HPLC within 60min. Addition-
ally, sewage water spiked with E1 (10 μM) was exposed to UV-B
irradiation and lumiestrone could be detected with HPLC within
1min (Figure A4 in Appendix). After 10min E1 was degraded but
lumiestrone persisted.
Is lumiestrone biologically active? A common screening strat-
egy for assessing estrogenicity of environmental chemicals involves
treatment of male ﬁsh and quantiﬁcation of estrogen-dependent
gene expression in the liver. The promoter of estrogen receptor
alpha (ERα) genes of teleost ﬁsh contain a functional, sensi-
tive, and characterized ERE. Thus, the auto-regulation response
of ERα serves as a sensitive physiologically relevant biomarker
for estrogenicity (Martyniuk et al., 2006, 2007; Marlatt et al.,
2008). Multiplex real-time RT-PCR determination of all three
known nuclear ERs in goldﬁsh revealed that E1 and E2 stimu-
lated 80- to 90-fold increases in hepatic ERα (p < 0.01; Figure A5
in Appendix), but not the other ER receptor subtypes. In marked
contrast, lumiestrone did not affect expression of any of these
genes (p > 0.05), suggesting that it is not estrogenic. Therefore
we pursued two other approaches to test if 13α-epimerization of
E1 indeed leads to complete loss of biological activity. All three
compounds were screened through established highly sensitive
reporter gene assays in vitro. Transfection of ER-negative U251-
MG human glial cells with zebraﬁsh ERα, ERβ1, ERβ2, and the
cyp19β-Luc reporter revealed that E1 and E2 activated all three
receptors. At high dose (at ﬁnal concentration 100-fold more than
E2 or E1), lumiestrone activated both zfERα and zfERβ2, but not
zfERβ1. Lumiestrone showed relatively higher estrogenic potency
with zfERβ2 than zfERα, suggesting that it may act through an
ERβ-selectivity (Figures 3A–C). This modest estrogenicity was
conﬁrmed in ERα and ERβ-positive human breast cancer MCF-7
cells transfected with the ERE-tk-Luc reporter. In both cell-based
assays, even at high concentrations (1000 nM), lumiestronedidnot
show full estrogenic activity but 20–70% of the maximal activity
induced by E2 (Figure 3D). This level of estrogenicity for lumie-
strone is similar to or greater than numerous other chemicals with
known endocrine disrupting activities (Andersen et al., 1999).
These in vitro results indicate that lumiestrone activates both
ﬁsh and human ER. As of yet, there are no known direct or
indirect gene targets of the ERβ2 in ﬁsh, therefore, we adopted
a microarray strategy to determine if indeed lumiestrone pos-
sess biological activity in vivo. Microarray screening of livers from
control and lumiestrone-injected male goldﬁsh revealed that a sin-
gle injection of the major E1 photoproduct is biologically active.
Statistical analysis indicated that 20 and 69 mRNAs were up-
or down-regulated, respectively. Of these 89 mRNAs, 22 were
identiﬁed using Blast2GO (Table A1 in Appendix; q < 5 and
fold change cutoff >1.4), while the remaining 67 were expressed
sequence tags that were not identiﬁable and were excluded from
further analysis. As determined by standard gene ontology classi-
ﬁcations, eight biological processes were affected by lumiestrone
(Table A1 in Appendix). These categorizations were statistically
signiﬁcant and include three to six identiﬁed genes (Table A1
in Appendix) related to signal transduction [6], cellular protein
metabolic processes [5], transport [4], macromolecule biosyn-
thetic processes [3], cellular biosynthetic processes [3], cellular
component assembly [3], organelle organization and biogenesis
[3], and DNA-dependent regulation of transcription [3]. Based
on the genes we could assign functions, the effects of lumiestrone
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FIGURE 3 | Screening transcriptional activities of estradiol (E2),
estrone (E1) and lumiestrone (LE) using estrogen receptor-dependent
reporter gene assays in vitro. ER-negative U251-MG glial cells were
transfected with zebraﬁsh ERα ( (A)), ERβ1 (B), and ERβ2 (C) and exposed
to estrogens or the dimethyl sulfoxide (DMSO) control. In (D) ERα and
ERβ-positive human breast cancer MCF-7 cells were used. Data are
presented as mean+SEM of luciferase activity relative to β-gal (n =3). Data
were tested for normality and homoscedasticity, and were transformed
when appropriate prior to analysis by one-way ANOVA (treatment;
p <0.001) followed byTukey’s post hoc test (S-Plus, v8.0). a,b,c,dMeans
labeled with different superscripts are signiﬁcantly different (p <0.05).
appear to be that of metabolic upset, perhaps linked to changes
in the various biosynthetic processes, and/or detoxiﬁcation. For
example, increased expression of glutathione S-transferase rho
may be expected to contribute to increased detoxiﬁcation, while
a decrease in cytochrome oxidase subunit 1 may be indicative
of reduced oxidative metabolism. At least three genes affected by
lumiestrone are indicative of endocrine disruption. Lumiestrone
decreased expression of a high-mobility box protein, which is
a coactivator that regulates ER binding to the ERE (Das et al.,
2004). Both somatostatin-1b and the type 2 somatostatin recep-
tor (SSTR2) were upregulated by lumiestrone, indicating an effect
on a growth regulatory system. It is noteworthy that the human
SSTR2 has functional EREs (Kimura et al., 2008). Somatostatins
and their receptors in the liver control ﬁbrogenesis in mammals
(Reynaert et al., 2005) and insulin-like growth factor production
in ﬁsh (Very et al., 2008). Importantly, only 25% (22/89) of the
differentially expressed genes could be identiﬁed, so other biologi-
cal pathways and effects of lumiestrone could be expected but will
require de-orphanization of these other expressed sequence tags.
Overall, both the in vitro reporter gene assays and the microarray
data indicate that lumiestrone is a biologically active estrogenic
derivative of E1.
To the best of our knowledge the hepatic transcriptional proﬁle
for E1 has not been determined in any ﬁsh. Direct comparison of
the microarray data obtained for lumiestrone to E1 is therefore
not possible at this time. Nevertheless, the hepatic transcriptional
responses to lumiestrone are clearly different frompreviously pub-
lished data for both steroidal and non-steroidal estrogenic EDCs
in two related Cyprinidae species, the common carp (Moens et al.,
2007) and zebraﬁsh (Martyniuk et al., 2007). The only similar-
ities we noted were the effects of these estrogenic chemicals on
glutamine synthetase (GS) and apolipoprotein, both of which are
also linked to metabolic effects. Glutamine synthetase-1 is upregu-
lated in carp liver after various estrogenic exposures (Moens et al.,
2007). Here we observed that lumiestrone upregulated glutamine
synthase-2. Glutamine synthetase catalyzes the ATP-dependent
formation of glutamine from ammonia and glutamate, and is
important for detoxiﬁcation of ammonia (Murray et al., 2003).
Moreover, GS may be an early marker for hepatocellular carci-
noma in humans (Long et al., 2010). In our previous work, the
contraceptive EE2 decreased apolipoprotein A1 mRNA in male
zebraﬁsh liver (Martyniuk et al., 2007), while here we observed a
decrease in hepatic apolipoprotein Eb mRNA after lumiestrone
treatment in male goldﬁsh. Apolipoproteins are important for
lipid transport, lipoprotein metabolic process and are implica-
tion in numerous conditions, for example, abnormalities of blood
lipids and in cardiovascular disease.
Analysis of samples fromawastewater treatment plant (Ottawa,
Canada) with secondary treatment indicates that lumiestrone is a
candidate environmental contaminant of concern. We detected
E1 in 100%, E2 in 55%, and both EE2 and lumiestrone in 10%
of samples of raw sewage (n = 10) and ﬁnal efﬂuent (n = 10).
Mean (±SD; with range) concentrations in sewage for E1, E2,
EE2, and lumiestrone were respectively, 103 (±21; 11–370), 18
(±21; 0–67), 0.14 (±0.4; 0–1.3), and 0.05 (±0.14; 0–0.46) ng/L.
Mean (±SD; with range) concentrations in ﬁnal efﬂuent for E1,
E2, EE2, and lumiestrone were respectively, 49 (±115; 35–103), 8
(±10; 0–27), 0.06 (±0.18; 0–0.6), and 0.03 (±0.1; 0–0.34) ng/L.
We have not determined at which stage in sewage handling and
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treatment that lumiestrone would be produced. However, the fre-
quency of detection of lumiestrone in the low ng/L range is similar
to EE2 in our study and also comparable to dozens pharmaceu-
ticals of concern already recognized as wastewater contaminants
(Kolpin et al., 2002; Metcalfe et al., 2003). Critically missing are
more detailed analyses of the steps in wastewater processing when
E1 could be converted to lumiestrone, more completely degraded
or sequestered by sediments.
Lumiestrone is photochemically produced from E1 and there-
fore is not directly of biological origin. It is plausible that lumie-
strone can be formed at any stage where sewage would be exposed
to sunlight. This suggestion is based on the short time and low level
of UV energy required to generate lumiestrone under experimen-
tal conditions in several aqueous media, and in sewage efﬂuent
exposed to natural sunlight. This could happen during transport
through sewage systems to the water treatment plant, during aera-
tion procedures, or in settling ponds prior to and after the release
to the aquatic receiving environment. Another possible process
that may produce lumiestrone in wastewater is during UV treat-
ment of sewage, which is beginning to be commonplace in some
countries (Das, 2001; Yoon et al., 2004; Hébert et al., 2008; Bilotta
and Daniel, 2010; Friedler and Gilboa, 2010).
In conclusion, we demonstrate UV-B-mediated production
of lumiestrone, a novel photoproduct derived from an environ-
mentally relevant estrogenic steroid. While sewage treatment has
improved considerably, there are still no widespread methods for
removing environmental estrogens that pose a risk to the health
of vertebrates (Guillette et al., 2007; Kidd et al., 2007; Hotckiss
et al., 2008; Ottinger et al., 2008; Desforges et al., 2010; Mourit-
sen et al., 2010; Decherf and Demeneix, 2011; Harris et al., 2011).
Most treatment facilities currently in operation are not designed to
remove natural or synthetic estrogens or the multitude of biologi-
cally active pharmaceuticals or chemicals found in personal health
care products. That one pollutant, E1, itself abundant and biolog-
ically active, can be transformed into an epimer with signiﬁcantly
different biological activity suggests that other phototransforma-
tions involving at least some of the hundreds of other EDCs found
in sewage and released into aquatic ecosystems over the world may
be possible. This will not only be an added problem for developed
nations where there is the possibility for secondary and tertiary
treatments including artiﬁcial UV treatments. In rural villages or
megacities in developing nations, it may be worse where sewage
from farms or urban and suburban regions is released without
any treatment. Given that sewage lagoons in swine, poultry, dairy,
and beef cattle farms all contain very high amounts of E1, and
numerous other estrogens in ng/L to μg/L range (Hutchins et al.,
2005), production of lumiestrone and other novel chemicals is
likely. Estrone can also be found in ocean sediments (Braga et al.,
2004) and persistence of estrogens from sewage biosolid applica-
tions to soil indicate that E1 is also in terrestrial environments
(Ying and Kookana, 2005). We showed that natural levels of solar
radiation can catalyze the formation of the new endocrine-active
pollutant lumiestrone. As we have done for EE2 (Al-Ansari et al.,
2010), it will be important in future studies to determine uptake
and bioconcentration potentials to fully understand the impact of
lumiestrone on aquatic vertebrates.
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APPENDIX
Materials and Methods and Results for the quenching of the transient bi-radical by nitric oxide are presented in Figure A1. Formation
of lumiestrone under several conditions is shown in Figures A2–A4. The effects of E1, E2 and lumiestrone on hepatic estrogen
receptor expression are shown in Figure A5. The candidate genes identiﬁed using cDNA microarrays as being differentially regulated
by lumiestrone are presented in Table A1.
FIGUREA1 | Quenching of the transient bi-radical by nitric oxide.
Electron paramagnetic resonance spectrum obtained upon irradiation of a
5×10−4-M solution of estrone in acetonitrile under UV-B. A solution of
estrone (0.5mM) dissolved in acetonitrile was degassed with nitrogen in
order to avoid in situ formation of nitric dioxide. The solution was then
saturated with a mixture containing 5% nitric oxide in nitrogen, and was
allowed to ﬂow through a conventional Electron paramagnetic resonance
spectroscopy (EPR) ﬂat cell (Suprasil) at a rate of 1mL/min. The solution
saturated with nitric oxide was continuously irradiated in the EPR cavity
by the means of a Xenon illuminator (model LUZ-XE, Luzchem). The EPR
spectra were recorded at room temperature on a FA-100 JEOL EPR
spectrometer. The experimental setting was as followed: microwave
power 1mW, modulation width 0.1mT, sweep time 1min, time constant
0.03 s.
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FIGUREA2 | Conversion of estrone into lumiestrone in water (ethanol <1%) following exposure to UV-B radiation followed by gas chromatography.
Irradiation times were (A) 0min, (B) 15min, (C) 45min.
FIGUREA3 | High-pressure liquid chromatography chromatograms of estrone solutions (10μM) irradiated by sunlight at different times. (A) t =0, (B)
t =15, (C) t =60, (D) t =120, and (E) t =180min. In order to simulate environmental conditions estrone was dissolved in untreated sewage water and
irradiated by sunlight in Napoli (Italy) in July 2007. HPLC analysis was performed under isocratic conditions (H2O/CH3CN 1:1) on an Agilent 1100 Binary HPLC
pumps system equipped with a UV-detector. The column used was a reverse-phase Gemini 5μ C-18 (250×4.60mm). The detector was set at 220 nm.
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FIGUREA4 | High-pressure liquid chromatography chromatograms of
estrone solutions (10μM) in untreated sewage water) irradiated by
UV-B (135μWcm−2; Helios Italquarz) for different times. (A) t =0, (B)
t =1min, (C) t =4min, and (D) t =10min. HPLC analysis under isocratic
conditions (H2O/CH3CN 1:1) was performed on an Agilent 1100 Binary
HPLC pumps system equipped with a UV-detector. The column used was
a reverse-phase Gemini 5μ C-18 (250×4.60mm). The detector was set at
220 nm.
FIGUREA5 |The effect of i.p. injections (0.5μg/g) of estradiol (E2),
estrone (E1), lumiestrone (LE), and control (charcoal-stripped peanut
oil; 5μL/g) on expression of liver estrogen receptor (ER)α in sexually
in sexually inactive male goldfish using multiplex real-time PCR (8)
after 24h. Data (n =6) are expressed as the mean (n =6; ±SEM) fold
change relative to the ERβ/β-actin ratios of the controls. Data were tested
for normality and homoscedasity, and were transformed when appropriate
prior to analysis by one-way ANOVA (treatment; p <0.001) followed by
Tukey’s post hoc test (S-Plus, v8.0). a,bMeans labeled with different
superscripts are signiﬁcantly different (p <0.05). Note that ER β1 and ER
β2 mRNAs were also measured in this PCR (not shown) but were not
affected by treatment (p >0.05). A subset (n =3) of samples was screened
by SYBR-Green-based PCR for vitellogenin-1 (VTG-1). VTGs are abundant
phosphoproteins normally produced in the female liver that are released
into circulation and accumulate in developing oocytes to provide
nourishment for developing ﬁsh larvae. The gene is largely silent and
undetectable in males unless they are exposed to estrogenic chemicals.
No VTG-1 transcripts were ampliﬁed from control or LE-treated samples
whereas it was detectable in all three of the samples from the E2 and
E1-treatment groups. These data followed the general pattern for ERα and
the average VTG-1/β-actin ratios for control, E2, E1, and LE were
respectively 0 (not-detectable), 4.2, 5.9, and 0 (not-detectable).
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Table A1 | Multilevel gene ontology classifications of transcripts expressed in male goldfish liver identified by version 1.1 of the goldfish-carp
cDNA microarray to be affected by lumiestrone.
Gene_ID Gene Blast X hit Biological process Molecular function Cellular component Direction q-Value Fold
Change
15b05 COP9 constitutive
photomorphogenic
homolog subunit 4
– Protein binding Cytoplasm,
signalosome
Down 3.65 1.635
25m12 TPA_exp: glutamine
synthetase
Glutamine
biosynthetic
process,
peptidoglycan
biosynthetic process
Glutamate–ammonia
ligase activity
– Up 3.99 1.553
27l09 High-mobility group
box 1
Regulation of
transcription,
DNA-dependent
DNA binding Chromatin, nucleus Down 3.65 1.407
28c20 Glutathione
S-transferase rho
– Transferase activity – Up 0 1.856
30g10 Integral membrane
protein 2B
Induction of
apoptosis
Protein binding, ATP
binding
Membrane fraction,
integral to
membrane,
mitochondrion
Down 3.65 1.430
30h23 Glucose-6-
phosphatase
– Hydrolase activity Membrane Up 0 1.843
30h24 FK506 binding
protein 5
Protein folding Peptidyl-prolyl
cis–trans isomerase
activity
– Up 0 1.811
39c13 Predicted: similar to
ribosomal protein S2
Translation, ribosome
biogenesis and
assembly
RNA binding,
structural constituent
of ribosome
Cytosolic small
ribosomal subunit
Up 0 1.540
40e24 Ribosomal protein
S15a, isoform
CRA_b
Translation, ribosome
biogenesis and
assembly
RNA binding,
structural constituent
of ribosome, protein
binding
Cytosolic small
ribosomal subunit
Up 0 1.711
42f19 Cytochrome oxidase
subunit I
Mitochondrial
electron transport
(cytochrome-c to
oxygen), aerobic
respiration, proton
transport
Cytochrome-c oxidase
activity, iron ion
binding, copper ion
binding, heme binding
Mitochondrial
respiratory chain,
respiratory chain
complex IV, integral
to membrane
Down 4.88 1.426
42m12 Beta-tubulin Microtubule-based
movement, spindle
assembly, protein
polymerization
GTPase activity, GTP
binding, structural
constituent of
cytoskeleton
Cytoplasm, tubulin
complex
Down 3.65 1.465
42n16 Apolipoprotein Eb Lipid transport,
negative regulation
of signal
transduction,
lipoprotein metabolic
process
Lipid binding Extracellular region,
signal recognition
particle
(endoplasmic
reticulum targeting)
Down 3.65 1.479
43k04 RTN4-M – – Endoplasmic
reticulum
Up 0 1.565
43n02 Somatostatin-1B
precursor
Signal transduction Hormone activity Extracellular region Up 3.23 1.481
(Continued)
Frontiers in Endocrinology | Experimental Endocrinology December 2011 | Volume 2 | Article 83 | 12
Trudeau et al. Lumiestrone is biologically active
Table A1 | Continued
Gene_ID Gene Blast X hit Biological process Molecular function Cellular component Direction q-Value Fold
Change
43p01 Somatostatin
receptor type 2
Neuropeptide
signaling pathway,
synaptic
transmission,
G-protein signaling
(adenylate cyclase
inhibiting pathway),
response to nutrient,
digestion, peristalsis,
negative regulation
of cell proliferation,
regulation of muscle
contraction
Somatostatin receptor
activity, PDZ domain
binding,
melanin-concentrating
hormone activity,
purinergic nucleotide
receptor activity
(G-protein coupled),
neuropeptideY
receptor activity
Membrane fraction,
integral to plasma
membrane
Up 0 1.575
54m19 Hypothetical protein
LOC553288
– UDP-
glucose:glycoprotein
glucosyltransferase
activity
– Down 3.65 1.451
55k21 Hypothetical protein
LOC564707
Transcription
initiation from RNA
polymerase II
promoter, androgen
receptor signaling
pathway, positive
regulation of
transcription from
RNA polymerase II
promoter
Thyroid hormone
receptor binding,
receptor activity, RNA
polymerase II
transcription mediator
activity,
ligand-dependent
nuclear receptor
transcription
coactivator activity,
vitamin D receptor
binding
Mediator complex,
transcription factor
complex
Down 3.65 1.513
59d21 Echinoderm
microtubule
associated protein
like 2
Regulation of
transcription,
DNA-dependent
– Microtubule Down 3.65 1.467
59d24 Transposase Transposition,
DNA-mediated
DNA binding,
transposase activity
– Down 0 1.547
59k22 RNA binding motif
protein, X-linked
– Nucleotide binding,
nucleic acid binding
Ribonucleoprotein
complex
Down 3.65 1.420
61g21 Hypothetical protein
LOC563359
Protein complex
assembly,
intracellular protein
transport, signal
transduction,
vesicle-mediated
transport, antigen
processing, and
presentation
(exogenous lipid
antigen via MHC
class Ib), positive
regulation of NKT
cell differentiation
Receptor activity,
protein binding,
protein transporter
activity
Golgi apparatus,
integral to
membrane,
membrane coat
Down 4.88 1.399
The microarray data have been submitted to GEO (GSE11252).
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